217 related articles for article (PubMed ID: 11145779)
1. Gamma-hydroxybutyrate overdose and physostigmine: teaching new tricks to an old drug?
Caldicott DG; Kuhn M
Ann Emerg Med; 2001 Jan; 37(1):99-102. PubMed ID: 11145779
[TBL] [Abstract][Full Text] [Related]
2. Physostigmine for gamma-hydroxybutyrate coma: inefficacy, adverse events, and review.
Zvosec DL; Smith SW; Litonjua R; Westfal RE
Clin Toxicol (Phila); 2007; 45(3):261-5. PubMed ID: 17453877
[TBL] [Abstract][Full Text] [Related]
3. The use of physostigmine in the management of gamma-hydroxybutyrate overdose.
Mullins ME; Dribben W
Ann Emerg Med; 2001 Sep; 38(3):347-8. PubMed ID: 11547795
[No Abstract] [Full Text] [Related]
4. Best evidence topic report. Gammahydroxybutyrate overdose and physostigmine.
Allen L; Alsalim W
Emerg Med J; 2006 Apr; 23(4):300-1. PubMed ID: 16549578
[No Abstract] [Full Text] [Related]
5. Physostigmine does not effect arousal but produces toxicity in an animal model of severe gamma-hydroxybutyrate intoxication.
Bania TC; Chu J
Acad Emerg Med; 2005 Mar; 12(3):185-9. PubMed ID: 15741579
[TBL] [Abstract][Full Text] [Related]
6. Physostigmine as a treatment for gamma-hydroxybutyrate toxicity: a review.
Traub SJ; Nelson LS; Hoffman RS
J Toxicol Clin Toxicol; 2002; 40(6):781-7. PubMed ID: 12475191
[TBL] [Abstract][Full Text] [Related]
7. [Physostigmine. From the God's judgment bean to modern antidote and therapeutic agent].
Walter K; Aschoff JC
Med Monatsschr Pharm; 1996 Sep; 19(9):252-60. PubMed ID: 8975106
[No Abstract] [Full Text] [Related]
8. Physostigmine: is there a role for this antidote in pediatric poisonings?
Frascogna N
Curr Opin Pediatr; 2007 Apr; 19(2):201-5. PubMed ID: 17496766
[TBL] [Abstract][Full Text] [Related]
9. Use of physostigmine in the management of gamma-hydroxybutyrate overdose.
Boyer EW; Quang L; Woolf A; Shannon M
Ann Emerg Med; 2001 Sep; 38(3):346; author reply 347-8. PubMed ID: 11524662
[No Abstract] [Full Text] [Related]
10. Physostigmine in the treatment of gamma-hydroxybutyric acid overdose.
Yates SW; Viera AJ
Mayo Clin Proc; 2000 Apr; 75(4):401-2. PubMed ID: 10761496
[TBL] [Abstract][Full Text] [Related]
11. Reversal of quetiapine-induced altered mental status with physostigmine: a case series.
Cole JB; Stellpflug SJ; Ellsworth H; Harris CR
Am J Emerg Med; 2012 Jul; 30(6):950-3. PubMed ID: 21802878
[TBL] [Abstract][Full Text] [Related]
12. Use of physostigmine for hallucinogenic plant poisoning in a teenager: case report and review of the literature.
Glatstein MM; Alabdulrazzaq F; Garcia-Bournissen F; Scolnik D
Am J Ther; 2012 Sep; 19(5):384-8. PubMed ID: 20861718
[TBL] [Abstract][Full Text] [Related]
13. [Jimson Weed poisoning: an antidote is available in France].
Lagarce L; Monteiro-Rodrigues A; Harry P
Presse Med; 2008 Mar; 37(3 Pt 1):435-7. PubMed ID: 18280100
[No Abstract] [Full Text] [Related]
14. Physostigmine salicylate as an antidote.
Daunderer M
Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):523-35. PubMed ID: 7228447
[TBL] [Abstract][Full Text] [Related]
15. [Gamma-hydroxybutyrate, a new central nervous system stimulant].
Strange DG; Jensen D
Ugeskr Laeger; 1999 Dec; 161(50):6934-6. PubMed ID: 10643381
[TBL] [Abstract][Full Text] [Related]
16. [Doctor, I need an antidote for your antidote. A case biperidene induced anticholinergic syndrome].
Carabaño Aguado I; Pelayo Baeza F; González-Valcárcel Sánchez-Puelles J
An Pediatr (Barc); 2010 May; 72(5):368-9. PubMed ID: 20378434
[No Abstract] [Full Text] [Related]
17. Use of a physostigmine continuous infusion for the treatment of severe and recurrent antimuscarinic toxicity in a mixed drug overdose.
Phillips MA; Acquisto NM; Gorodetsky RM; Wiegand TJ
J Med Toxicol; 2014 Jun; 10(2):205-9. PubMed ID: 24798647
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system depression after ingestion of RenewTrient.
Nelson LS; Howland MA; Hoffman RS
N Engl J Med; 1999 Feb; 340(7):570. PubMed ID: 10026059
[No Abstract] [Full Text] [Related]
19. Survival of massive gamma-hydroxybutyrate/1,4-butanediol overdose.
Strickland RM; Felgate P; Caldicott DG
Emerg Med Australas; 2005 Jun; 17(3):281-3. PubMed ID: 15953232
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes in children with hyoscyamus niger intoxication not receiving physostigmine therapy.
Doneray H; Orbak Z; Karakelleoglu C
Eur J Emerg Med; 2007 Dec; 14(6):348-50. PubMed ID: 17968201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
